2017

XThis page contains elements that are not optimised for mobile viewing. Click the link below to view the page in desktop mode.

Desktop mode

Go to main content

Consultation responses on the future reimbursement status of 5 combination products in ATC groups C07, C08 and C09

| 02 February 2009 |

The Danish Medicines Agency's assessment of the future reimbursement status of 5 combination products in ATC groups C07, C08 and C09 for the treatment of cardiovascular diseases has been submitted for consultation with 11 December 2008 as the consultation deadline.